Customize
Quick Links

Accreditation/
Credit Designation

Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC, designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669 for 2.0 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Regeneron.

About
Accreditation
Privacy Policy
Terms & Conditions
Executive Board
Journal
Faculty Portal
Contact
Facebook
Twitter
LinkedIn
Google +
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2017
Physicians’ Education Resource ®, LLC.
All rights reserved.

ASCO: New Directions in Advanced Cutaneous Squamous Cell Carcinoma: Emerging Evidence of Immunotherapy

ASCO: New Directions in Advanced Cutaneous Squamous Cell Carcinoma: Emerging Evidence of Immunotherapy


Date: Saturday, June 2, 2018

Time: 7:00 PM – 9:00 PM
Dinner and registration: 6:30 PM – 7:00 PM

Location:
Hilton Hotel
International Ballroom South (Second Level)
720 S. Michigan Avenue
Chicago, IL 60605

Overview

Patients with unresectable cutaneous squamous cell carcinoma (cSCC) respond to any currently available treatment only about 30% of the time. Cutaneous SCC is a devastating skin cancer with limited beneficial treatment options. Surgeries to remove cSCC tumors can be disfiguring, and elderly individuals often are not candidates for chemotherapeutic agents because they cannot tolerate the toxicity. There is a clearly unmet clinical need for improved cytoreductive strategies that may mitigate deleterious surgical outcomes in these treatment settings.

This live CME satellite symposium will be presented as an ancillary event to the 2018 ASCO Annual Meeting, and will feature expert faculty discussing advances in oncology immunotherapies for the treatment of advanced or metastatic cSCC, including the most recent data sets; the role of personalized, multidisciplinary, team-based patient management; and adverse event considerations. In particular, experts will provide clinical context concerning noteworthy evidence in cancer immunotherapy, their take on how this impacts patient care, and how to safely apply these novel approaches for busy clinicians who attend major oncology conferences, such as the ASCO Annual Meeting.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Regeneron.

Target Audience

This educational activity is directed toward medical oncologists. Nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other healthcare professionals interested in the treatment of cSCC are also invited to participate. The enduring activity will additionally be targeting those involved in the multidisciplinary care of patients with cSCC, including medical dermatologists, surgeons, head and neck cancer surgeons, and Mohs surgeons.

Learning Objectives

After successful completion of this educational activity, participants should be better able to:

  • Discuss current unmet clinical needs in the management of advanced/metastatic cSCC and evidence-based recommendations for the care of patients with these tumors
  • Determine the rationale for the development of cytoreductive strategies for the management of patients with advanced/metastatic cSCC
  • Report recent evidence concerning the use of emerging immunotherapeutic approaches for the treatment of patients with advanced or metastatic cSCC
  • Describe multidisciplinary approaches to plan for and proactively mitigate the impact of immune-related adverse events in patients who are undergoing treatment for advanced/metastatic cSCC

Program Chair:

Jason Luke, MD, FACP
Assistant Professor of Medicine
The University of Chicago Medicine
Chicago, IL







Become a Member

Forgot Password?
Filter By